American Society of Hematology

Fig. 3.

Fig. 3. Overall survival (OS) and disease-free survival (DFS) curves based on bax/bcl-2 ratio within the CD34+ subset. / Lower than 0.3 bax/bcl-2 ratio retained its striking poor prognostic effect with regard to OS (A) (P = .000 01) and DFS (B) (P = .04).

Overall survival (OS) and disease-free survival (DFS) curves based on bax/bcl-2 ratio within the CD34⁺ subset.

Lower than 0.3 bax/bcl-2 ratio retained its striking poor prognostic effect with regard to OS (A) (P = .000 01) and DFS (B) (P = .04).

This Feature Is Available To Subscribers Only

Sign In or Create an Account